What targeted therapies are available for Head and Neck Cancer

Targeted Therapies for Head and Neck Cancer

I'll walk you through the targeted therapy options that are currently available for head and neck cancer, based on current medical guidelines.

What Are Targeted Therapies?

Targeted therapies are drugs designed to attack specific characteristics of cancer cells—like particular genetic mutations or proteins on the cell surface—rather than attacking all rapidly dividing cells like traditional chemotherapy does. This approach often means fewer side effects because normal cells aren't affected as much.

Current Targeted Therapy Options

1. FGFR-Targeted Therapy: Erdafitinib

According to the NCCN Guidelines for Head and Neck Cancers, erdafitinib is now available for patients with:

• FGFR mutations or fusions (genetic changes in the FGFR gene)
• Recurrent, unresectable, or metastatic disease
• Disease that has progressed after at least one prior line of systemic therapy
• Limited alternative systemic therapy options

What this means: If your tumor has an FGFR mutation, this targeted drug may be an option worth discussing with your oncologist.

2. Immunotherapy (PD-1/PD-L1 Inhibitors)

While technically immunotherapy rather than "targeted" in the traditional sense, these drugs target specific immune checkpoint proteins:

Pembrolizumab is used in several settings:

• Neoadjuvant setting (before surgery) for patients with PD-L1 positive tumors
• Adjuvant setting (after surgery/radiation) combined with radiation therapy
• Recurrent/metastatic disease in PD-L1 positive patients

Other PD-1 inhibitors like nivolumab may be considered for certain head and neck cancer types, particularly nasopharyngeal cancers.

3. Cetuximab (EGFR-Targeted Therapy)

Cetuximab targets the EGFR protein (epidermal growth factor receptor) found on some head and neck cancer cells. According to NCCN Guidelines, it may be used:

• Combined with radiation therapy in certain situations
• As part of combination therapy for recurrent or metastatic disease

How Doctors Decide Which Targeted Therapy to Use

NCCN Guidelines emphasize that treatment selection should be individualized based on:

1. Biomarker testing - Your tumor should be tested for:

   • Combined Positive Score (CPS) for PD-L1
   • FGFR mutations or fusions
   • Tumor Mutational Burden (TMB)
   • Microsatellite Instability (MSI)
   • HER2 status
   • Next-generation sequencing (NGS) genomic profiling

2. Your performance status - How well you're functioning overall

3. Your goals of therapy - Whether treatment aims to cure or manage symptoms

4. Disease stage and location - Where the cancer is and how advanced it is

5. Prior treatments - What you've already received

Important Questions to Ask Your Oncologist

Since targeted therapy selection is highly personalized, here are specific questions to discuss:

1. "Has my tumor been tested for FGFR mutations, PD-L1 status, and other biomarkers? If not, can we do that testing?"

2. "Based on my specific biomarker results, which targeted therapies would be appropriate for my situation?"

3. "Am I a candidate for pembrolizumab or other immunotherapy? What does my PD-L1 score mean?"

4. "What are the side effects of the targeted therapy you're recommending, and how do they compare to chemotherapy?"

5. "Are there clinical trials available that might include targeted therapies I haven't tried yet?"

6. "If my first targeted therapy doesn't work, what are my next options?"

Key Takeaway

The field of targeted therapy for head and neck cancer is evolving. According to the NCCN Guidelines, next-generation sequencing and biomarker testing are now recommended to guide treatment decisions. This means your individual tumor's genetic profile—not just the cancer type—should help determine which targeted therapy might work best for you.

The most important step is ensuring your tumor has been comprehensively tested for these biomarkers so you and your care team can make informed decisions about which targeted approach is right for your specific situation.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.